An individualized innovative disease management is of great importance for people with
multiple sclerosis (pwMS) to cope with the complexity of this chronic, multidimensional …

Most patients with multiple sclerosis (MS) eventually experience walking disability. The
objective of this review was to evaluate the clinical utility of measures specific for walking in …

The Canadian Multiple Sclerosis Working Group (CMSWG) developed practical
recommendations in 2004 to assist clinicians in optimizing the use of disease-modifying …

Background: In persons with multiple sclerosis (PwMS) resistance training improves muscle
strength but effects on walking capacity are inconsistent. Objective: The objective was to …

Background: Many different walking capacity test formats are being used. It is unclear
whether walking speed, obtained from short tests, and walking distance, obtained from long …

Objectives: To investigate the prevalence of joint contracture (limited passive range of joint
motion) and muscle weakness in a population with multiple sclerosis (MS). A secondary aim …

Background: Persons with multiple sclerosis (MS) commonly have difficulty walking. The 6-
Minute Walk Test (6MWT) assesses functional capacity but may be considered burdensome …

Objective. To investigate the individual occurrence of walking-related motor fatigue in
persons with multiple sclerosis (PwMS), according to disability level and disease phenotype …

Multiple Sclerosis (MS) is often seen in young adults and known to cause both physical and
cognitive disability, and it is quite important to make an objective assessment of the physical …

Abstract Background Although the Six-Minute Walk Test (6MWT), as recommended by the
American Thoracic Society, is widely used as a measure of functional endurance, it may not …